Farmacia hospitalaria
Especialidad
Eva
Ardanaz Aicua
Publicaciones en las que colabora con Eva Ardanaz Aicua (12)
2021
-
Occupational heat exposure and breast cancer risk in the MCC-Spain study
Cancer Epidemiology Biomarkers and Prevention, Vol. 30, Núm. 2, pp. 364-372
-
Sleep duration and napping in relation to colorectal and gastric cancer in the MCC-Spain study
Scientific Reports, Vol. 11, Núm. 1
2020
-
Association between polyphenol intake and breast cancer risk by menopausal and hormone receptor status
Nutrients, Vol. 12, Núm. 4
-
Cancer cure for 32 cancer types: Results from the EUROCARE-5 study
International Journal of Epidemiology, Vol. 49, Núm. 5, pp. 1517-1525
-
Circulating bilirubin levels and risk of colorectal cancer: serological and Mendelian randomization analyses
BMC medicine, Vol. 18, Núm. 1, pp. 229
-
Dietary and circulating fatty acids and ovarian cancer risk in the European Prospective Investigation into Cancer and Nutrition
Cancer Epidemiology Biomarkers and Prevention, Vol. 29, Núm. 9, pp. 1739-1749
-
Exogenous hormone use and cutaneous melanoma risk in women: The European Prospective Investigation into Cancer and Nutrition
International Journal of Cancer, Vol. 146, Núm. 12, pp. 3267-3280
-
Quality of life in a cohort of 1078 women diagnosed with breast cancer in spain: 7-year follow-up results in the mcc-spain study
International Journal of Environmental Research and Public Health, Vol. 17, Núm. 22, pp. 1-16
-
Reasons for low cervical cancer survival in new accession European Union countries: a EUROCARE-5 study
Archives of Gynecology and Obstetrics, Vol. 301, Núm. 2, pp. 591-602
2019
-
Moderate egg consumption and all-cause and specific-cause mortality in the Spanish European Prospective into Cancer and Nutrition (EPIC-Spain) study
European Journal of Nutrition, Vol. 58, Núm. 5, pp. 2003-2010
2018
-
Childhood and adolescent lymphoma in Spain: incidence and survival trends over 20 years
Clinical and Translational Oncology, Vol. 20, Núm. 10, pp. 1289-1301
-
Receptor activator of nuclear factor kB ligand, osteoprotegerin, and risk of death following a breast cancer diagnosis: Results from the EPIC cohort
BMC Cancer, Vol. 18, Núm. 1